107 related articles for article (PubMed ID: 27501029)
1. Interleukin (IL) 31 induces in cynomolgus monkeys a rapid and intense itch response that can be inhibited by an IL-31 neutralizing antibody.
Lewis KE; Holdren MS; Maurer MF; Underwood S; Meengs B; Julien SH; Byrnes-Blake KA; Freeman JA; Bukowski TR; Wolf AC; Hamacher NB; Rixon MW; Dillon SR
J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):142-150. PubMed ID: 27501029
[TBL] [Abstract][Full Text] [Related]
2. Cynomolgus monkey model of interleukin-31-induced scratching depicts blockade of human interleukin-31 receptor A by a humanized monoclonal antibody.
Oyama S; Kitamura H; Kuramochi T; Higuchi Y; Matsushita H; Suzuki T; Goto M; Adachi H; Kasutani K; Sakamoto A; Iwayanagi Y; Kaneko A; Nanami M; Fujii E; Esaki K; Takashima Y; Shimaoka S; Hattori K; Kawabe Y
Exp Dermatol; 2018 Jan; 27(1):14-21. PubMed ID: 27714851
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis.
Gonzales AJ; Humphrey WR; Messamore JE; Fleck TJ; Fici GJ; Shelly JA; Teel JF; Bammert GF; Dunham SA; Fuller TE; McCall RB
Vet Dermatol; 2013 Feb; 24(1):48-53.e11-2. PubMed ID: 23331679
[TBL] [Abstract][Full Text] [Related]
4. IL-4 and IL-13 are not involved in IL-31-induced itch-associated scratching behaviour in mice.
Kawai R; Ichimasu N; Katagiri K
Exp Dermatol; 2024 Jun; 33(6):e15115. PubMed ID: 38855893
[TBL] [Abstract][Full Text] [Related]
5. A single dose of interleukin-31 (IL-31) causes continuous itch-associated scratching behaviour in mice.
Arai I; Tsuji M; Takeda H; Akiyama N; Saito S
Exp Dermatol; 2013 Oct; 22(10):669-71. PubMed ID: 24079740
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge.
Hawro T; Saluja R; Weller K; Altrichter S; Metz M; Maurer M
Allergy; 2014 Jan; 69(1):113-7. PubMed ID: 24251414
[TBL] [Abstract][Full Text] [Related]
7. Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice.
Kasutani K; Fujii E; Ohyama S; Adachi H; Hasegawa M; Kitamura H; Yamashita N
Br J Pharmacol; 2014 Nov; 171(22):5049-58. PubMed ID: 24946165
[TBL] [Abstract][Full Text] [Related]
8. Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis.
Grimstad O; Sawanobori Y; Vestergaard C; Bilsborough J; Olsen UB; Grønhøj-Larsen C; Matsushima K
Exp Dermatol; 2009 Jan; 18(1):35-43. PubMed ID: 19054054
[TBL] [Abstract][Full Text] [Related]
9. Involvement of thromboxane A
Andoh T; Li S; Uta D
Pharmacol Rep; 2018 Apr; 70(2):251-257. PubMed ID: 29477033
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-4 and interleukin-13 evoke scratching behaviour in mice.
Campion M; Smith L; Gatault S; Métais C; Buddenkotte J; Steinhoff M
Exp Dermatol; 2019 Dec; 28(12):1501-1504. PubMed ID: 31505056
[TBL] [Abstract][Full Text] [Related]
11. Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis.
Takaoka A; Arai I; Sugimoto M; Honma Y; Futaki N; Nakamura A; Nakaike S
Exp Dermatol; 2006 Mar; 15(3):161-7. PubMed ID: 16480423
[TBL] [Abstract][Full Text] [Related]
12. Establishment of an Intradermal Canine IL-31-Induced Pruritus Model to Evaluate Therapeutic Candidates in Atopic Dermatitis.
Pearson J; Leon R; Starr H; Kim SJ; Fogle JE; Banovic F
Vet Sci; 2023 May; 10(5):. PubMed ID: 37235412
[TBL] [Abstract][Full Text] [Related]
13. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys.
Hart TK; Cook RM; Zia-Amirhosseini P; Minthorn E; Sellers TS; Maleeff BE; Eustis S; Schwartz LW; Tsui P; Appelbaum ER; Martin EC; Bugelski PJ; Herzyk DJ
J Allergy Clin Immunol; 2001 Aug; 108(2):250-7. PubMed ID: 11496242
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic modeling of a humanized anti-IL-13 antibody in naive and Ascaris-challenged cynomolgus monkeys.
Vugmeyster Y; Tian X; Szklut P; Kasaian M; Xu X
Pharm Res; 2009 Feb; 26(2):306-15. PubMed ID: 18975059
[TBL] [Abstract][Full Text] [Related]
15. Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice.
Berman RM; Suzuki T; Tahara H; Robbins PD; Narula SK; Lotze MT
J Immunol; 1996 Jul; 157(1):231-8. PubMed ID: 8683120
[TBL] [Abstract][Full Text] [Related]
16. IL-13 blockade reduces lung inflammation after Ascaris suum challenge in cynomolgus monkeys.
Bree A; Schlerman FJ; Wadanoli M; Tchistiakova L; Marquette K; Tan XY; Jacobson BA; Widom A; Cook TA; Wood N; Vunnum S; Krykbaev R; Xu X; Donaldson DD; Goldman SJ; Sypek J; Kasaian MT
J Allergy Clin Immunol; 2007 May; 119(5):1251-7. PubMed ID: 17379289
[TBL] [Abstract][Full Text] [Related]
17. Vital role of the itch-scratch response in development of spontaneous dermatitis in NC/Nga mice.
Mihara K; Kuratani K; Matsui T; Nakamura M; Yokota K
Br J Dermatol; 2004 Aug; 151(2):335-45. PubMed ID: 15327540
[TBL] [Abstract][Full Text] [Related]
18. Exploring the Potentiality of a Plant Platform for Monoclonal Antibody Production in Veterinary Medicine.
Morel B; Favrot C; Mirande L; Grünwald-Gruber C; Stordeur V; Vezina LP; Faye L; Gomord V
Vaccines (Basel); 2024 Jun; 12(6):. PubMed ID: 38932349
[TBL] [Abstract][Full Text] [Related]
19. Ethanol aggravates itch-related scratching in hairless mice developing atopic dermatitis.
Fujii M; Nakamura T; Fukuno S; Mizutani N; Nabe T; Kohno S
Eur J Pharmacol; 2009 Jun; 611(1-3):92-9. PubMed ID: 19344707
[TBL] [Abstract][Full Text] [Related]
20. IL-31: a new link between T cells and pruritus in atopic skin inflammation.
Sonkoly E; Muller A; Lauerma AI; Pivarcsi A; Soto H; Kemeny L; Alenius H; Dieu-Nosjean MC; Meller S; Rieker J; Steinhoff M; Hoffmann TK; Ruzicka T; Zlotnik A; Homey B
J Allergy Clin Immunol; 2006 Feb; 117(2):411-7. PubMed ID: 16461142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
